Becton Dickinson (BD) is a global medical technology company with more than 125 years in operation, employing approximately 75,000 associates and operating in nearly every country. The company's technical domains span medical technology, diagnostics, life sciences, interventional technologies, safety-engineered medical devices, and automated diagnostic systems. BD delivers billions of products annually and invests more than $1 billion each year in R&D.
For robotics engineers, BD's work in automated diagnostic systems and safety-engineered medical devices presents relevant engineering challenges. The company pioneered the first safety-engineered syringe and has developed automated diagnostic platforms that operate at scale in clinical environments. These systems require integration across hardware and software boundaries - precision fluidics, sensor arrays, mechanical actuation, and control software must meet stringent regulatory and reliability constraints inherent to medical devices used on the frontlines of patient care.
BD operates across three main segments: Medical, Life Sciences, and Interventional. Engineering teams work on technologies that address complex healthcare delivery problems, from diagnostic automation to device safety mechanisms. The scale of deployment - billions of units annually across nearly every country - means designs must account for manufacturing variability, diverse clinical environments, and regulatory requirements across multiple jurisdictions.
